The USAN Council, which includes representatives from the American Medical Association (AMA), the United States Pharmacopeia (USP), and the Food and Drug Administration (FDA), collaborates to assign these names. The process involves:
Submission of a name request by a pharmaceutical company. Review by the USAN Council for uniqueness, simplicity, and potential for confusion with existing names. Approval or modification of the proposed name.
